P1.01-06 Comparative Effectiveness of First Line (1L) Therapies for Advanced Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.721 ◽

2019 ◽

Vol 14 (10) ◽

pp. S356-S357

Author(s):

S. Goring ◽

T. Li ◽

A. Gara ◽

N. Varol ◽

B. Korytowsky ◽

...

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Comparative Effectiveness ◽

Small Cell Lung ◽

Download Full-text

Modeling Challenges in Cost-Effectiveness Analysis of First-Line Immuno-Oncology Therapies in Non-small Cell Lung Cancer: A Systematic Literature Review

PharmacoEconomics ◽

10.1007/s40273-021-01089-4 ◽

2021 ◽

Author(s):

Thitima Kongnakorn ◽

Grammati Sarri ◽

Andreas Freitag ◽

Kinga Marczell ◽

Paulina Kazmierska ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Effectiveness Analysis

Download Full-text

PCN22 BURDEN OF BRAIN METASTASES (BM) IN ALK+ NON-SMALL CELL LUNG CANCER (ALK+ NSCLC) TREATED WITH FIRST-LINE ALK INHIBITORS: RESULTS OF A SYSTEMATIC LITERATURE REVIEW (SLR)

Value in Health ◽

10.1016/j.jval.2019.09.219 ◽

2019 ◽

Vol 22 ◽

pp. S439

Author(s):

X. Pan ◽

C.S. Kwon ◽

S.A. Garib ◽

A. Forsythe ◽

H.M. Lin

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Download Full-text

PCN116 Economic Impact of First-Line (1L) Immunotherapies in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)

Value in Health ◽

10.1016/j.jval.2020.08.253 ◽

2020 ◽

Vol 23 ◽

pp. S443-S444

Author(s):

G. Sarri ◽

A. Freitag ◽

P. Kazmierska ◽

B. Lin ◽

V. Pawar ◽

...

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Economic Impact ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Download Full-text

PCN130 Modeling Approaches in Cost-Effectiveness Analysis (CEA) of First-Line (1L) Immuno-Oncology (IO) Therapies in Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)

Value in Health ◽

10.1016/j.jval.2020.08.267 ◽

2020 ◽

Vol 23 ◽

pp. S446

Author(s):

T. Kongnakorn ◽

A. Walker ◽

G. Sarri ◽

A. Freitag ◽

K. Marczell ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Effectiveness Analysis

Download Full-text

Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis

Current Medical Research and Opinion ◽

10.1080/03007995.2020.1790346 ◽

2020 ◽

Vol 36 (9) ◽

pp. 1497-1505

Author(s):

Ticiana A. Leal ◽

Angela C. Argento ◽

Krish Bhadra ◽

D. Kyle Hogarth ◽

Julia Grigorieva ◽

...

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

Prognostic Performance

Download Full-text

PCN155 AN ECONOMIC SYSTEMATIC LITERATURE REVIEW FOR UNTREATED ANAPLASTIC LYMPHOMA KINASE-POSITIVE (ALK+) NON-SMALL-CELL LUNG CANCER (NSCLC)

Value in Health ◽

10.1016/j.jval.2019.09.351 ◽

2019 ◽

Vol 22 ◽

pp. S465

Author(s):

R. Robson ◽

A. Prowse ◽

A. Strickson ◽

C. Cooper

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxane-based Chemotherapy for Stage IV Non–Small-cell Lung Cancer in a US Community Oncology Setting

Clinical Lung Cancer ◽

10.1016/j.cllc.2016.12.008 ◽

2017 ◽

Vol 18 (4) ◽

pp. 372-380.e1 ◽

Author(s):

Jared Weiss ◽

Rex W. Force ◽

Brook A. Pugmire ◽

Teri Peterson ◽

Claudio Faria ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Comparative Effectiveness ◽

Stage Iv ◽

Resource Usage ◽

Small Cell Lung ◽

Community Oncology

Download Full-text

PCN7 COMPARATIVE EFFECTIVENESS ASSESSMENT OF ERLOTINIB VERSUS GEFITINIB IN FIRST-LINE EGFR ACTIVATING MUTATION POSITIVE NON-SMALL CELL LUNG CANCER

Value in Health ◽

10.1016/j.jval.2011.02.865 ◽

2011 ◽

Vol 14 (3) ◽

pp. A155 ◽

Author(s):

B. Schwander ◽

J. de Castro Carpeño ◽

D.F. Heigener ◽

E. Wright ◽

H.G. Bischoff ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Comparative Effectiveness ◽

Small Cell Lung ◽

Activating Mutation ◽

Effectiveness Assessment

Download Full-text

Prolonged Response of Meningeal Carcinomatosis from Non-small Cell Lung Cancer to Salvage Intrathecal Etoposide Subsequent to Failure of First-Line Methotrexate: A Case Report and Literature Review

American Journal of Case Reports ◽

10.12659/ajcr.894061 ◽

2015 ◽

Vol 16 ◽

pp. 224-227 ◽

Author(s):

Min Jae Park

Keyword(s):

Lung Cancer ◽

Case Report ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meningeal Carcinomatosis ◽

Small Cell Lung ◽

Prolonged Response

Download Full-text

Systematic Literature Review For Treatment Outcomes (Including Immuno-Oncology Treatment) Among Patients with Stage 3 Unresectable Non-Small Cell Lung Cancer (NSCLC)

Value in Health ◽

10.1016/j.jval.2017.08.110 ◽

2017 ◽

Vol 20 (9) ◽

pp. A416 ◽

Author(s):

Z Zhou ◽

J Song ◽

MJ Ouwens ◽

M Huhn ◽

H Jiang ◽

...

Keyword(s):

Lung Cancer ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Treatment Outcomes ◽

Systematic Literature Review ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Oncology Treatment

Download Full-text